Portfolio Update

RNS Number : 2331A

Intl. Biotechnology Trust PLC

22 March 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 28 February 2017

Net Assets	£248m
Net Assets per share	661p
Share price	590p
Total value of unquoted investments	£24m
Total number of portfolio companies	87

Top Ten Holdings

Company Name	% NAV
Celgene	7.6
Incyte	7.2
Biogen	7.0
Alexion	5.3
Genmab	4.3
Amgen	4.3
Regeneron	4.2
Shire	4.0
Illumina	3.3
Vertex	3.2
	-----------
Total	50.4

Geographical Allocation	% NAV
US & Canada	85
Europe & UK	15
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	90
Unquoted	10
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	61
Mid Cap =USD1-10BN	19
Small Cap <USD1BN	20
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	39
Orphan	13
CNS	9
Inflammation	8
Ophthalmology	6
Medtech	2
Other	23
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

22 MARCH 2017

 

END

 

 

PFUBSGDXDUDBGRD